Quebec’s RSV immunization program greatly lowered infant hospitalizations, study says

Quebec’s universal respiratory syncytial virus immunization program proved more than 85 per cent effective in reducing infant hospitalizations, emergency-room consultations and intensive-care admissions, according to a new study.

The province was the first in Canada to announce a publicly funded nirsevimab program for the 2024-25 RSV season. Ontario, Nunavut, Yukon and the Northwest Territories later followed suit.